{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:08:52Z","timestamp":1775142532811,"version":"3.50.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Polyvalent hyperimmune sera are widely used for emergency passive immunoprophylaxis; however, controlled experimental evidence supporting their safety and preventive efficacy remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this study, three polyantigenic hyperimmune sera were evaluated using a standardized white mouse bacterial challenge model. Sera were generated through stepwise immunization of donor animals with monovalent and polyvalent antigenic formulations targeting enteric and respiratory pathogens. Sterility and safety were assessed prior to\n                      <jats:italic>in vivo<\/jats:italic>\n                      application. Preventive efficacy was evaluated following subcutaneous administration of sera 24\u202fh before experimental infection with enteric bacterial pathogens.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Serological characterization confirmed robust virus- and bacteria-specific humoral responses in donor animals, with end-point antibody titers reaching up to 1:2560 in serum preparations containing viral antigens. All tested sera were sterile and well tolerated, with no adverse clinical effects observed during the monitoring period. Prophylactic administration led to a marked increase in survival compared with untreated controls across multiple bacterial challenge models, with absolute risk reduction values ranging from 40 to 100%. In contrast, native serum collected prior to immunization provided only partial or no protection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Overall, these findings provide controlled experimental evidence demonstrating the safety, immunogenicity, and reproducible preventive efficacy of polyvalent hyperimmune sera in a murine bacterial infection model, supporting their consideration as candidate immunobiological agents for passive protection against bacterial infections under controlled experimental conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fvets.2026.1810086","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:35:16Z","timestamp":1775140516000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Sterility, safety, and preventive efficacy of three polyvalent hyperimmune sera against bacterial infection in a white mouse challenge model"],"prefix":"10.3389","volume":"13","author":[{"given":"Ibragim","family":"Tutkyshbay","sequence":"first","affiliation":[{"name":"Mukhtar Auezov South Kazakhstan University","place":["Shymkent, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxat","family":"Berdikulov","sequence":"additional","affiliation":[{"name":"National Veterinary Reference Center","place":["Almaty, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zura","family":"Yessimsiitova","sequence":"additional","affiliation":[{"name":"Al-Farabi Kazakh National University","place":["Almaty, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abzal","family":"Makhmutov","sequence":"additional","affiliation":[{"name":"Kazakh National Agrarian Research University","place":["Almaty, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damir","family":"Khussainov","sequence":"additional","affiliation":[{"name":"Kazakh National Agrarian Research University","place":["Almaty, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulzhan","family":"Mussayeva","sequence":"additional","affiliation":[{"name":"National Veterinary Reference Center","place":["Almaty, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raikhan","family":"Nissanova","sequence":"additional","affiliation":[{"name":"Kazakh Scientific Research Veterinary Institute, LLP","place":["Almaty, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuandyk","family":"Shynybayev","sequence":"additional","affiliation":[{"name":"Kazakh Scientific Research Veterinary Institute, LLP","place":["Almaty, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flyura","family":"Bakiyeva","sequence":"additional","affiliation":[{"name":"LLP NPTTS \u201cZhalyn\u201d","place":["Almaty, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitriy","family":"Taranov","sequence":"additional","affiliation":[{"name":"LLP NPTTS \u201cZhalyn\u201d","place":["Almaty, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"104235","DOI":"10.1016\/j.cellimm.2020.104235","article-title":"Immunogenic properties of immunoglobulin superfamily members within complex biological networks","volume":"358","author":"Odales","year":"2020","journal-title":"Cell Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/v15071543","article-title":"Hyperimmune globulins for the management of infectious diseases","volume":"15","author":"Pati","year":"2023","journal-title":"Viruses"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/poultry4010008","article-title":"Protective effect of a hyperimmune serum against homologous Enterococcus cecorum infection in experimentally challenged meat-type chickens","volume":"4","author":"Rosenbaum","year":"2025","journal-title":"Poult"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.14202\/IJOH.2025.121-127","article-title":"Preparation of hyperimmune serum against multidrug-resistant Escherichia coli isolated from animal products in Bali and Nusa Tenggara, Indonesia: an epidemiological perspective","volume":"11","author":"Tenaya","year":"2025","journal-title":"Int J One Health"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/evj.13858","article-title":"Transfusion of hyperimmune plasma for protecting foals against Rhodococcus equi pneumonia","volume":"55","author":"Kahn","year":"2023","journal-title":"Equine Vet J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3390\/v15071436","article-title":"Passive transfer of animal-derived polyclonal Hyperimmune antibodies provides protection of mice from lethal Lassa virus infection","volume":"15","author":"Oestereich","year":"2023","journal-title":"Viruses"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/microorganisms9010121","article-title":"Intravenous immunoglobulins at the crossroad of autoimmunity and viral infections","volume":"9","author":"Perricone","year":"2021","journal-title":"Microorganisms"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41587-021-00894-8","article-title":"Generation of recombinant hyperimmune globulins from diverse B-cell repertoires","volume":"39","author":"Keating","year":"2021","journal-title":"Nat Biotechnol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"987231","DOI":"10.3389\/fimmu.2022.987231","article-title":"Polyvalent human immunoglobulin for infectious diseases: potential to circumvent antimicrobial resistance","volume":"13","author":"Pedraza-S\u00e1nchez","year":"2023","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.3390\/biomedicines11113022","article-title":"Multifaceted tissue-protective functions of polyvalent immunoglobulin preparations in severe infections\u2014interactions with neutrophils, complement, and coagulation pathways","volume":"11","author":"Schmidt","year":"2023","journal-title":"Biomedicine"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/life11020144","article-title":"The road towards polyclonal anti-SARS-CoV-2 immunoglobulins (Hyperimmune serum) for passive immunization in COVID-19","volume":"11","author":"Focosi","year":"2021","journal-title":"Life"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/toxins15090517","article-title":"Polyvalent Snake Antivenoms: production strategy and their therapeutic benefits","volume":"15","author":"Ratanabanangkoon","year":"2023","journal-title":"Toxins"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/15569543.2022.2124421","article-title":"Production of hyperimmune sera: a study of digestion and fractionation methodologies for the purification process of heterologous immunoglobulins","volume":"42","author":"Da Costa","year":"2023","journal-title":"Toxin Rev"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.21608\/jcvr.2023.296053","article-title":"A review on the clinical efficacy of antitetanic hyperimmune serum prepared in equine using Freund adjuvants in response to toxoid and toxin immunization","volume":"5","author":"Saleh","year":"2023","journal-title":"J Curr Vet Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.11134\/btp.3.2024.7","article-title":"Selection of strong positive serum samples from cattle infected with bovine viral diarrhea","volume":"1","author":"Bashenova","year":"2024","journal-title":"Eurasian J Appl Biotechnol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3390\/v17101341","article-title":"Bovine viral diarrhea in Kazakhstan","volume":"17","author":"Bashenova","year":"2025","journal-title":"Viruses"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.11134\/btp.3.2025.12","article-title":"Preparation of hyperimmune sera for SARS-COV-2 virus","volume":"1","author":"Nakhanova","year":"2025","journal-title":"Eurasian J Appl Biotechnol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/CCM.0b013e318236f486","article-title":"The use of hyperimmune serum for severe influenza infections*","volume":"40","author":"Rockman","year":"2012","journal-title":"Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.69849\/revistaft\/ar10202410301045","article-title":"O uso de soro hiperimune na cl\u00ednica de pequenos animais","volume":"28","author":"Godoy","year":"2024","journal-title":"Revft"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1128\/jcm.25.11.2173-2180.1987","article-title":"Hyperimmune serum from rabbits immunized with potassium thiocyanate extract of Pasteurella multocida protects against homologous challenge","volume":"25","author":"Lu","year":"1987","journal-title":"J Clin Microbiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1099\/vir.0.068270-0","article-title":"Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity","volume":"95","author":"Habiela","year":"2014","journal-title":"J Gen Virol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"107220","DOI":"10.1016\/j.intimp.2020.107220","article-title":"COVID-19 and Hyperimmune sera: a feasible plan B to fight against coronavirus","volume":"90","author":"Da Costa","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"893921","DOI":"10.3389\/fimmu.2022.893921","article-title":"Hyperimmune targeting staphylococcal toxins effectively protect against USA 300 MRSA infection in mouse bacteremia and pneumonia models","volume":"13","author":"Han","year":"2022","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1732852","DOI":"10.1080\/19490976.2020.1732852","article-title":"Oral delivery of hyperimmune bovine serum antibodies against CS6-expressing enterotoxigenic Escherichia coli as a prophylactic against diarrhea","volume":"12","author":"Talaat","year":"2020","journal-title":"Gut Microbes"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.52783\/jisem.v10i44s.8646","article-title":"Hyperimmune sera in the treatment and prevention of diarrhea in neonatal calves","volume":"10","author":"Mutushev","year":"2025","journal-title":"J Inf Syst Eng Manage"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"693439","DOI":"10.3389\/fviro.2021.693439","article-title":"Defining efficacy of chikungunya virus candidate vaccines: different endpoints derived from the virus\u2014cytokine\u2014ferritin (VCF) model","volume":"1","author":"Lim","year":"2021","journal-title":"Front Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1201\/9780429187445-14","volume-title":"Medical Uses of Statistics","author":"Lagakos","year":"2019"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/geronj\/39.1.36","article-title":"On statistical tests of significance in studies of survivorship in laboratory animals","volume":"39","author":"Mode","year":"1984","journal-title":"J Gerontol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/bjs.10237","article-title":"Statistical analyses that provide an effect size are to be preferred","volume":"103","author":"Cook","year":"2016","journal-title":"Br J Surg"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1177\/106002809302701018","article-title":"Meaningful interpretation of risk reduction from clinical drug trials","volume":"27","author":"McCormack","year":"1993","journal-title":"Ann Pharmacother"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1017\/S1466252315000195","article-title":"Passive immunization with hyperimmune egg-yolk IgY as prophylaxis and therapy for poultry diseases \u2013 a review","volume":"16","author":"Gadde","year":"2015","journal-title":"Anim Health Res Rev"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1093\/jpids\/piae058","article-title":"Passive immunization strategies to prevent severe respiratory syncytial virus infection among newborns and young infants","volume":"13","author":"Suryadevara","year":"2024","journal-title":"J Pediatr Infect Dis Soc"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1810086\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:35:17Z","timestamp":1775140517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1810086\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":32,"alternative-id":["10.3389\/fvets.2026.1810086"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2026.1810086","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"article-number":"1810086"}}